Celularity Company
Celularity is a clinical-stage biotechnology company developing off-the-shelf placental-derived allogeneic cell therapies.
Investors
Technology:
CAR-T, Cell-based gene therapy
Industry:
CAR-T, Public
Headquarters:
Florham Park, New Jersey, United States
Founded Date:
2017-09-01
Employees Number:
101-250
Funding Status:
IPO
Investors Number:
12
Total Funding:
400000011
Estimated Revenue:
$50M to $100M
Last Funding Date:
2022-05-26
Last Funding Type:
Post-IPO Equity
Register and Claim Ownership